IP Verse

Formulations Which Stabilize And Inhibit Precipitation Of Immunogenic Compositions - EP2676679

The patent EP2676679 was granted to Wyeth on Aug 28, 2024. The application was originally filed on Apr 19, 2007 under application number EP13185292A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2676679

WYETH
Application Number
EP13185292A
Filing Date
Apr 19, 2007
Status
Patent Maintained As Amended
Jul 26, 2024
Grant Date
Aug 28, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SANOFI PASTEUR INCSANOFI AVENTIS DEUTSCHLAND GMBHSANOFI WINTHROP INDUSTRIESOct 2, 2019ZWICKERADMISSIBLE
SK BIOSCIENCEOct 2, 2019ZWICKERADMISSIBLE
MERCK SHARP & DOHMEOct 2, 2019VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBWITHDRAWN

Patent Citations (38) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS20060795098-
DESCRIPTIONEP1296713
DESCRIPTIONEP1326634
DESCRIPTIONUS4673574
DESCRIPTIONUS4902506
DESCRIPTIONUS4912094
DESCRIPTIONUS5057540
DESCRIPTIONUS5078996
DESCRIPTIONUS5254339
DESCRIPTIONUS5614382
DESCRIPTIONUS5723127
DESCRIPTIONUS6113918
DESCRIPTIONUS6207646
DESCRIPTIONUS6270775
DESCRIPTIONUS6355255
DESCRIPTIONUS6951653
DESCRIPTIONWO0018434
DESCRIPTIONWO02098368
DESCRIPTIONWO02098369
DESCRIPTIONWO03063766
DESCRIPTIONWO2004065603
DESCRIPTIONWO2004083251
DESCRIPTIONWO2004094596
DESCRIPTIONWO9219265
DESCRIPTIONWO9313302
OPPOSITIONUS4902506
OPPOSITIONUS5932223
OPPOSITIONUS8562999
OPPOSITIONWO0108495
OPPOSITIONWO03009869
OPPOSITIONWO2004071439
OPPOSITIONWO2005014037
OPPOSITIONWO2006110381
SEARCHEP2425856
SEARCHUS2004047882
SEARCHWO0141800
SEARCHWO0205846
SEARCHWO2007060548

Non-Patent Literature (NPL) Citations (62) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BALDWIN, "Contamination of insulin by silicone oil: A potential hazard of plastic insulin syringes", DIABET. MED., (1988), vol. 5, pages 789 - 790-
DESCRIPTION- BARTZOKA; BROOK; MCDORMOTT, "Protein-Silicone Films: Establishing the Strength of the Protein-Silicone Interaction", LANGMUIR, (1998), vol. 14, pages 1892 - 1898-
DESCRIPTION- BARTZOKA; BROOK; MCDORMOTT, "Protein-Silicone Interactions: How Compatible Are the Two Species?", LANGMUIR, (1998), vol. 14, pages 1887 - 1891-
DESCRIPTION- BARTZOKA; CHAN; BROOK, "Protein-Silicone Synergism at Liquid/Liquid Interfaces", LANGMUIR, (2000), vol. 16, pages 4589 - 4593-
DESCRIPTION- BERNSTEIN, "Clouding and deactivation of clear (regular) human insulin: Association with silicone oil from disposable syringes?", DIABETES CARE, (1987), vol. 10, pages 786 - 787-
DESCRIPTION- BERNSTEIN, "Clouding and Deactivation of Clear (Regular) Human Insulin: Association with Silicone Oil from Disposable Syringes", DIABETES CARE, (1987), vol. 1 0, pages 786 - 787-
DESCRIPTION- BOLGIANO ET AL., "Effect of Physico-Chemical Modification on the Immunogenicity of Haemophilus influenzae Type b Oligosaccharide-CRM197 Conjugate Vaccines", VACCINE, (2001), vol. 19, pages 3189 - 3200-
DESCRIPTION- CHANTELAU; BERGER, "Pollution of insulin with silicone oil, a hazard of disposable plastic syringes", LANCET, (1985), vol. 1, page 1459-
DESCRIPTION- CHANTELAU; BURGER; BOHLKEN, "Silicone Oil Released from Disposable Insulin Syringes", DIABETES CARE, (1986), vol. 9, pages 672 - 673-
DESCRIPTION- CHANTELAU ET AL., "Silicone oil released from disposable insulin syringes", DIABETES CARE, (1986), vol. 9, pages 672 - 673-
DESCRIPTION- CHANTELAU, "Silicone oil contamination of insulin", DIABET. MED., (1989), vol. 6, page 278-
DESCRIPTION- COLLIER; DAWSON, "Insulin syringes and silicone oil", LANCET, (1985), vol. 5, pages 789 - 790-
DESCRIPTION- HO ET AL., "Physico-Chemical and Immunological Examination of the Thermal Stability of Tetanus Toxoid Conjugate Vaccines", VACCINE, (2002), vol. 20, pages 3509 - 3522-
DESCRIPTION- HO ET AL., "Solution Stability of the Subunit Components of Meningococcal C Oligosaccharide-CRM197 Conjugate Vaccines", BIOTECH. APPL. BIOCHEM., (2001), vol. 33, pages 91 - 98-
DESCRIPTION- JONES ET AL., "Silicone Oil Induced Aggregation of Proteins", J. PHARMACEUTICAL SCI., (2005), vol. 94, no. 4, pages 918 - 927-
DESCRIPTION- KAJIHARA ET AL., "Development of new drug delivery system for protein drugs using silicone", J. CONTROL. REL., (2000), vol. 66, pages 49 - 61-
DESCRIPTION- "Protein -Silicone Interactions at Liquid-Liquid Interfaces", BARTZOKA; BROOK; MCDORMOTT, Emulsions, Foams and Thin Films, DEKKER, (2000), pages 371 - 380-
DESCRIPTION- SUN ET AL., "Protein Denaturation Induced by Cyclic Silicone", BIOMATERIALS, (1998), vol. 18, pages 1593 - 1597-
OPPOSITION- AKERS et al., "Development and Manufacture of Protein Pharmaceuticals", Pharm. Biotech., (20020000), vol. 14, pages 47 - 128, XP055449337-
OPPOSITION- Anonymous, "A reliable route from drug to patient - BD Hypakâ„¢ Glass Prefillable Syringe", BD Medical Pharmaceutical Systems, (20100000), pages 1 - 12, XP055647380-
OPPOSITION- Anonymous, "BD Hypak prefilled syringes", BD Hypak, (20000000), pages 1 - 8, XP055650200-
OPPOSITION- Anonymous, "Pneumococcal 7-valent Conjugate Vaccine (Diphteria CRM197 Protein) Prevnar® for pediatric use only", Wyeth-Ayers Laboratories, (20030500), pages 1 - 30, XP055647351-
OPPOSITION- Anonymous, "Prefilled Syringes: Innovations That Meet the Growing Demand", On drug delivery, (20050000), pages 1 - 28, XP055059297-
OPPOSITION- Anonymous, "Scientific Discussion for the approval for Prevenar", EMEA, (20050000), pages 1 - 16, XP055650052-
OPPOSITION- Anonymous, "Study evaluating pneumococcal vaccine in healthy infants", Clinical Trials.gov Identified NCT00205803, (20050919), pages 1 - 5, XP055650029-
OPPOSITION- Anonymous, "Study to evaluate a 13-valent pneumococcal conjugate vaccine in elderly subjects", Clinical Trials.gov Identified NCT00269672, (20051223), pages 1 - 5, XP055650021-
OPPOSITION- Anonymous, "Summary of Product Characteristics - Prevenar suspension for injection", Vossius Ref.: AB3173 EP/1/OPP S3,, (20050125), pages 1 - 15, XP055650060-
OPPOSITION- Anonymous, "Summary of Product Characteristics - Prevenar suspension for injection", Vossius ref.: AB3173 EP/1/OPP S3, (20190000), vol. 13, XP055650203-
OPPOSITION- BARRETT, "Human immune response to polysaccharide antigens: An analysis of bacterial polysaccharide vaccines in infants", Advances in Petiatrics VOLUME 32, (19850000), pages 139 - 158, XP055650067-
OPPOSITION- DAUM et al., "INFANT IMMUNIZATION WITH PNEUMOCOCCAL CRM197 VACCINES: EFFECT OF SACCHARIDE SIZE ON IMMUNOGENICITY AND INTERACTIONS WITH SIMULTANEOUSLY ADMINISTERED VACCINES", The Journal of Infectious Diseases, (19970000), vol. 176, no. 2, pages 445 - 455, XP001041718-
OPPOSITION- De La Peña C; Sánchez M M; Suárez M, "Presente y futuro de la vacunación antineumocócica", Pediatrika, (20040000), vol. 24, no. 4, pages 147 - 155, XP055162952-
OPPOSITION- De La Peña C; Sánchez M M; Suárez M, "Presente y futuro de la vacunación antineumocócica", Pediatrika, (20040000), vol. 24, no. 4, pages 47 - 55, XP055162952-
OPPOSITION- DE LA PENA, "Presente y futuro de la vacunación antineumococica", Geriatrika, (20040000), vol. 24, no. 4, pages 147 - 155, XP055162952-
OPPOSITION- DR. KHANDKE, "Utilization of Biophysical Tools To Characterize Vaccines", AAPS National Biotech Conference, (20150607), pages 1 - 39, XP055650039-
OPPOSITION- Franklin Lakes, "BD Medical Continues Advancement of Flu Vaccine Delivery Technologies", BD News & Information, (20060131), pages 1 - 2, URL: https://www.bd.com/contentmanager/b_article.asp?Item_ID=22407, XP055647389-
OPPOSITION- Franklin Lakes, N.J., "Wyeth Infant Meningitis Vaccine Available for Delivery with BD Hypak SCFâ„¢ Prefill System", BD - News & Information, (20060721), pages 1 - 2, URL: https://www.bd.com/contentmanager/b_article.asp?Item_ID=22617, XP055647384-
OPPOSITION- Franklin Lakes, N.J., "Wyeth Infant Meningitis Vaccine Available for Delivery with BD Hypak SCFâ„¢ Prefill System", BD News & Information, (20060721), pages 1 - 2, URL: https://www.bd.com/contentmanager/b_article.asp?Item_ID=22617, XP055647384-
OPPOSITION- HO et al., "Solution stability studies of the subunit components of meningococcal C oligosaccharide-CRM 197 CONJUGATE VACCINES", Biotechnol. Appl. Biochem, (20010000), vol. 33, pages 91 - 98, XP055650216-
OPPOSITION- J. SMITH et al., "Technical Report No. 12 - Siliconization of Parenteral Drug Packaging Components", Journal of Parenteral Science and Technology, (19880000), vol. 42, no. 4S, pages S3 - S14, XP055647345-
OPPOSITION- KATKOCIN, "Characterization of Multivalent Pneumococcal 2000 Conjugate Vaccines '', in: '' Physico-Chemical Procedures for the Characterization of Vaccines", Dev Biol., Basel, (20000000), vol. 103, pages 113 - 119-
OPPOSITION- KATKOCIN, "Characterization of Multivalent Pneumococcal 2000 Conjugate Vaccines '', in: '' Physico-Chemical Procedures for the Characterization of Vaccines", Dev Biol., Basel, (20000000), vol. 103, pages 113 - 119, XP009070656-
OPPOSITION- KELLNER et al., "Serotype replacement in invasive streptococcus pneumoniae (ISP) infections after introduction of 7-valent pneumococcal conjugate vaccine (PCV7) in Canada: implications for an expanded 13- valent vaccine", 5th International 2 Symposium on Pneumococci and Pneumococcal Disease in Alice Springs, (20060405), page 1, XP055650215-
OPPOSITION- Khande et al., "PDA - The Universe of Pre-filled Syringes and Injection Devices", Wyeth research, Berlin, (20071128), pages 1 - 15, XP055650193-
OPPOSITION- POLIN, "The evolution of parental drug packaging", Pharm Med Packaging News, (20040000), pages 67 - 75, XP055650198-
OPPOSITION- "Prevnar 13 - wyeth/3403", Anonymous, Physicians' Desk Reference PDR 65 EDITION, (20110000), pages 1 - 8, XP055650187-
OPPOSITION- RAPPUOLI et al., "Chapter 8", Vaccines, (19990000), pages 201 - 224, XP055650045-
OPPOSITION- SCOTT et al., "Safety and immunogenicity of the 13- valent pneumococcal conjugate vaccine in healthy adults", 5th International 1 Symposium on Pneumococci and Pneumococcal Disease in Alice Springs, (20060405), XP055650211-
OPPOSITION- SHALAEV, "The Impact of Buffer on Processing and Stability of Freeze-Dried Dosage Forms, Part 1: Solution Freezing Behavior", American Pharmaceutical Review, (20050100), vol. 8, no. 5, pages 80 - 87, XP009153586-
OPPOSITION- SMITH et al., "Siliconization of Parenteral Drug Packaging Components", Journal of Parenteral Science and Technology, (19880000), vol. 42, no. 4S, pages S3 - S14, XP055647345-
OPPOSITION- SMITH et al., "Technical Report No. 12 Siliconization of Parenteral Drug Packaging Components", J. Parent. Sci. Techn., (19880000), vol. 42, XP055647345-
OPPOSITION- "World`s first lubricant-free prefillable glass syringe launched at DCAT 2019", (20190325), URL: https://www.schott.com/english/news/press.html ?NID=com5588-
OPPOSITION- "World`s first lubricant-free prefillable glass syringe launched at DCAT 2019", (20190325), URL: https://www.schott.com/english/news/press.html?NID=com5588-
OPPOSITION- JONES et al., "Silicone oil induced aggregation of proteins", Journal of Pharmaceutical Sciences, (20050000), vol. 94, no. 4, pages 918 - 927, XP002509400
OPPOSITION- RUBIN, "Pneumococcal vaccine", Pediatric Clinics of North America, (20000400), vol. 47, no. 2, pages 269 - 285, XP055650209
OPPOSITION- CUTTS et al., "Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial", Lancet, (20050326), vol. 365, pages 1139 - 1146, XP004808115
OPPOSITION- BOLGIANO et al., "Effect of physico-chemical modification on the immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM"1"9"7 conjugate vaccines", Vaccine, (20010000), vol. 19, pages 3189 - 3200, XP004234191
OPPOSITION- OVERTURF, "Pneumococcal vaccination of children", Seminars in Pediatric Infectious Diseases, (20020700), vol. 13, no. 3, pages 155 - 164, XP055330430
OPPOSITION- MBELLE et al., "Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine", The Journal of Infectious Diseases, (19990000), vol. 180, pages 1171 - 1176, XP002393672
OPPOSITION- O'BRIEN et al., "Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases", America l Journal of Epidemiology, (20040000), vol. 159, no. 7, pages 634 - 644, XP055163991
OPPOSITION- OBARO et al., "SAFETY AND IMMUNOGENECITIY OF A NONAVALENT PNEUMOCOCCAL VACCINE CONJUGATED TO CRM197 ADMINISTERED SIMULTANEOUSLY BUT IN A SEPARATE SYRINGE WITH DIPHTHERIA, TETANUS AND PERTUSSIS VACCINES IN GAMBIAN INFANTS", Pediatr Infect Dis J, (20000000), vol. 19, no. 5, pages 463 - 469, XP008067219
OPPOSITION- ZHANG et al., "Mucosal immune responses to meningococcal conjugate polysaccharide vaccines in infants", Pediatr. Infect. Dis. J., (20020000), vol. 21, no. 3, pages 209 - 213, XP055650071
OPPOSITION- OBARO et al., "Safety and immunogenicity of pneumococcal conjugate vaccine in combination with diphtheria, tetanus toxoid, pertussis and Haemophilus influenzae type b conjugate vaccine", Pediatr. Infect Dis J, (20020000), vol. 21, pages 940 - 946, XP002970992

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents